Navigation Links
Pets Best Announces New Underwriter for Pet Insurance Policies
Date:12/15/2008

BOISE, Idaho, Dec. 15 /PRNewswire/ -- Pets Best Insurance LLC (Pets Best) announced today that effective December 12, 2008, new policies will be underwritten by Aetna Insurance Company of Connecticut (AICC) in Alabama, District of Columbia, Idaho, Iowa, Montana, North Dakota and Texas. The change will strengthen Pets Best's overall position in the industry and provide a better platform for the continued growth of its mission to protect pets throughout the U.S. Existing policy holders will be automatically notified when policies roll over to AICC-underwritten coverage.

"This will be a seamless transition for our existing customers and will allow us to provide more options for pet owners, including increased coverage and additional deductible levels," said Jack Stephens DVM, President of Pets Best Insurance. "In these uncertain economic times, we want pet owners to know that they don't have to deal with pet accidents and illnesses alone. Now more than ever, we want people to know about their options for protection."

Pets Best plans will remain competitively priced, with reimbursements based on a straightforward 80% of veterinary bills after the deductible. Premium rates with AICC will be based on experience by breed, pet age and the typical veterinary costs within each policy holder's local area.

Pets Best and AICC will work together to extend outreach to pet owners, communicating the value of budgeting for unexpected accidents and illness through reliable, affordable insurance. Plans will include a choice of higher deductibles for pet owners who want to lower the cost of their premiums. The expanded range of options will give policyholders the ability to design plans around their budget and risk tolerance.

Importantly, Pets Best plans underwritten by AICC have earned the exclusive recommendation of the American Veterinary Medical Association Group Health and Life Insurance Trust (
'/>"/>

SOURCE Pets Best Insurance LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lilly Announces Dividend Increase
2. Anthem Blue Cross and Blue Shield and Summerlin Life and Health Insurance Company Enter Into Endorsement Agreement as Summerlin Announces Exit From the Commercial PPO Business in Nevada
3. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
4. Musculoskeletal Transplant Foundation Announces Major Development Milestone in Stem Cell Allograft Product
5. DaVita Inc. Announces Receipt of DOJ Subpoena in Connection with Previously Reported Investigation
6. Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
7. Alfacell Announces Management Update
8. Wyeth Announces Positive Data from Phase 2 Study of Neratinib in Advanced HER-2-Positive Breast Cancer
9. Par Pharmaceutical Announces the Resignation of Its Chief Financial Officer
10. Schering-Plough Announces FDA Approval of PEGINTRON(TM) and REBETOL(R) Combination Therapy for Treating Pediatric Hepatitis C
11. AmericInn Hotels Partners With Nationally Recognized Sleep Expert Dr. Christopher Drake, Announces Launch of Sleep Better America Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 2Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 3Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 4Health News:New book presents comprehensive survey of research into the molecular basis of aging 2Health News:BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards 2Health News:BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards 3Health News:Fluoridated water for Queensland ... at last 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 3Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 4Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 5Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 6Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 7Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 8
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 1Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 2Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13865 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 2Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 3
Other Medicine Technology:Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 2Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 3Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 4Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 5Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 5